FXTAS, SCA10, and SCA17 in American patients with movement disorders.
Seixas
Ana I
AI
Maurer
Martin H
MH
Lin
Mark
M
Callahan
Colleen
C
Ahuja
Alka
A
Matsuura
Tohru
T
Ross
Christopher A
CA
Hisama
Fuki M
FM
Silveira
Isabel
I
Margolis
Russell L
RL
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001259:Ataxia / Q000235:genetics / Q000473:pathology*; D002648:Child; D002675:Child, Preschool; D005260:Female; D051860:Fragile X Messenger Ribonucleoprotein 1; D005600:Fragile X Syndrome / Q000473:pathology*; D006801:Humans; D008297:Male; D018895:Microsatellite Repeats / Q000235:genetics; D008875:Middle Aged; D009069:Movement Disorders / Q000235:genetics / Q000473:pathology*; D009419:Nerve Tissue Proteins / Q000235:genetics; D016601:RNA-Binding Proteins / Q000235:genetics; D020754:Spinocerebellar Ataxias / Q000235:genetics / Q000473:pathology*; D035181:TATA-Box Binding Protein / Q000235:genetics; D014202:Tremor / Q000235:genetics / Q000473:pathology*; D019680:Trinucleotide Repeat Expansion / Q000235:genetics; D014481:United States
D051860:Fragile X Messenger Ribonucleoprotein 1; D009419:Nerve Tissue Proteins; D016601:RNA-Binding Proteins; D035181:TATA-Box Binding Protein; C497683:FMR1 protein, human